BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kostoff RN, Briggs MB, Porter AL, Spandidos DA, Tsatsakis A. [Comment] COVID‑19 vaccine safety. Int J Mol Med 2020;46:1599-602. [PMID: 33000193 DOI: 10.3892/ijmm.2020.4733] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao T, Shen J, Zhu Y, Tian X, Wen G, Wei Y, Xu B, Fu C, Xie Z, Xi Y, Li Z, Peng J, Wu Y, Tang X, Wan C, Pan L, Li Z, Qin D. Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series. Front Public Health 2022;10:875558. [DOI: 10.3389/fpubh.2022.875558] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu L, Wang X, Li X, Li N. COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted. Front Public Health 2022;10:819062. [DOI: 10.3389/fpubh.2022.819062] [Reference Citation Analysis]
3 Kostoff RN, Kanduc D, Porter AL, Shoenfeld Y, Calina D, Briggs MB, Spandidos DA, Tsatsakis A. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol Rep 2020;7:1448-58. [PMID: 33110761 DOI: 10.1016/j.toxrep.2020.10.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
4 Yu CS, Chang SS, Chang TH, Wu JL, Lin YJ, Chien HF, Chen RJ. A COVID-19 Pandemic Artificial Intelligence-Based System With Deep Learning Forecasting and Automatic Statistical Data Acquisition: Development and Implementation Study. J Med Internet Res 2021;23:e27806. [PMID: 33900932 DOI: 10.2196/27806] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Al Ghafri TS, Al Balushi L, Al Balushi Z, Al Hinai F, Al Hasani S, Anwar H, Al Lawati M, Al Harthi S. Reporting at Least One Adverse Effect Post-COVID-19 Vaccination From Primary Health Care in Muscat. Cureus 2021;13:e17055. [PMID: 34522533 DOI: 10.7759/cureus.17055] [Reference Citation Analysis]
6 Lariccia V, Magi S, Serfilippi T, Toujani M, Gratteri S, Amoroso S. Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review. J Clin Med 2020;9:E4021. [PMID: 33322733 DOI: 10.3390/jcm9124021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Bilotta C, Perrone G, Adelfio V, Spatola GF, Uzzo ML, Argo A, Zerbo S. COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis. Front Immunol 2021;12:729251. [PMID: 34912330 DOI: 10.3389/fimmu.2021.729251] [Reference Citation Analysis]
8 Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, Asadi-Aliabadi M, Nojomi M. Adverse effects following COVID-19 vaccination in Iran. BMC Infect Dis 2022;22:476. [PMID: 35585518 DOI: 10.1186/s12879-022-07411-5] [Reference Citation Analysis]
9 Frank A, Radparvar S, Manasia A, Bassily-Marcus A, Kohli-Seth R. Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action. Crit Care Explor 2021;3:e0397. [PMID: 33834172 DOI: 10.1097/CCE.0000000000000397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tai W, Chow MYT, Chang RYK, Tang P, Gonda I, MacArthur RB, Chan HK, Kwok PCL. Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19. Pharmaceutics 2021;13:1260. [PMID: 34452220 DOI: 10.3390/pharmaceutics13081260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Guo Y, Hu K, Li Y, Lu C, Ling K, Cai C, Wang W, Ye D. Targeting TNF-α for COVID-19: Recent Advanced and Controversies. Front Public Health 2022;10:833967. [DOI: 10.3389/fpubh.2022.833967] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
12 Esam Z, Akhavan M, Lotfi M, Bekhradnia A. Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight. J Mol Struct 2022;1247:131394. [PMID: 34483364 DOI: 10.1016/j.molstruc.2021.131394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li L, Honda-Okubo Y, Huang Y, Jang H, Carlock MA, Baldwin J, Piplani S, Bebin-Blackwell AG, Forgacs D, Sakamoto K, Stella A, Turville S, Chataway T, Colella A, Triccas J, Ross TM, Petrovsky N. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection. Vaccine 2021;39:5940-53. [PMID: 34420786 DOI: 10.1016/j.vaccine.2021.07.087] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Adigwe OP. COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria. Vaccine X 2021;9:100112. [PMID: 34494000 DOI: 10.1016/j.jvacx.2021.100112] [Reference Citation Analysis]